Immutep Announces Final Results In Phase I/II Chemoimmunotherapy Trial In Metastatic

		HER2 Support Group Forums > Breast Cancer Newsfeed
Immutep Announces Final Results In Phase I/II Chemoimmunotherapy Trial In Metastatic

09-07-2010, 07:10 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,958	Immutep Announces Final Results In Phase I/II Chemoimmunotherapy Trial In Metastatic Immutep S.A. announced the publication of a clinical research paper showing that its lead product, IMP321, given with first-line paclitaxel achieved clinical benefit in 90 per cent of metastatic breast carcinoma (MBC) patients. Correlations were observed with both the patients' monocyte (i.e... More...

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 09:42 AM.